Cargando…
How the VALID Act could affect patient access to laboratory developed testing for therapeutic drug monitoring
• LDTs are important to lab medicine as they allow flexibility for laboratories to provide testing that patients need. • Many TDMs are LCMS-based and are considered LDTs. • Some TDMs currently have little to no options for obtaining FDA cleared testing. • The VALID Act may threaten the offering of L...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969055/ https://www.ncbi.nlm.nih.gov/pubmed/36861048 http://dx.doi.org/10.1016/j.jmsacl.2023.02.004 |